Shares of Cepheid (NASDAQ: CPHD), a molecular diagnostics company engaged in the development, manufacturing and marketing of integrated systems for testing in the Clinical market, are soaring in early trading today.
Continue reading Major Movers on December 28; CPHD, AMD, HCA, GRPN, ARNA, FB, BAC, RIMM